Back to MORGAN STANLEY

TSHA
8 quarters

Position history for MORGAN STANLEY's holdings in TAYSHA GENE THERAPIES INC

MORGAN STANLEY holds 18M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $80.3M as of 2026-Q1. The position was decreased (-0.6% shares). TSHA represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$80.3M

Current Shares

18M

Total Value Change

+$63.6M

Total Shares Change

+10.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
18M
-0.6%
$80.3M0.0%$4.53
0
2025-Q4
Decreased
18.1M
-6.4%
$99.4M0.0%$5.66
0
2025-Q3
Increased
19.3M
+14.5%
$63.1M0.0%$3.16
34
2025-Q2
Increased
16.9M
+0.1%
$39M0.0%$2.38
29
2025-Q1
Decreased
16.8M
-4.5%
$23.4M0.0%$1.93
0
2024-Q4
Increased
17.6M
+130.2%
$30.5M0.0%$1.73
46
2024-Q3
Increased
7.7M
+2.5%
$15.4M0.0%$2.07
29
2024-Q2
New
7.5M
-
$16.7M0.0%$2.24
39

Other major holders of TSHA: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc., GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used